GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Total Assets

Firebrick Pharma (ASX:FRE) Total Assets : A$1.95 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Total Assets?

Firebrick Pharma's Total Assets for the quarter that ended in Dec. 2023 was A$1.95 Mil.

During the past 12 months, Firebrick Pharma's average Total Assets Growth Rate was -10.60% per year.

Total Assets is connected with ROA %. Firebrick Pharma's annualized ROA % for the quarter that ended in Dec. 2023 was -72.90%. Total Assets is also linked to Revenue through Asset Turnover. Firebrick Pharma's Asset Turnover for the quarter that ended in Dec. 2023 was 0.74.


Firebrick Pharma Total Assets Historical Data

The historical data trend for Firebrick Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Total Assets Chart

Firebrick Pharma Annual Data
Trend Jun21 Jun22 Jun23
Total Assets
11.77 8.73 2.98

Firebrick Pharma Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Total Assets 8.73 5.63 2.98 1.95

Firebrick Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Firebrick Pharma's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets=Total Equity (A: Jun. 2023 )+Total Liabilities (A: Jun. 2023 )
=2.476+0.506
=2.98

Firebrick Pharma's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=1.589+0.356
=1.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Firebrick Pharma  (ASX:FRE) Total Assets Explanation

Total Assets is connected with ROA %.

Firebrick Pharma's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-1.796/( (2.982+1.945)/ 2 )
=-1.796/2.4635
=-72.90 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Firebrick Pharma's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1.816/( (2.982+1.945)/ 2 )
=1.816/2.4635
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Firebrick Pharma Total Assets Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Firebrick Pharma (ASX:FRE) Business Description

Traded in Other Exchanges
N/A
Address
440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of Nasodine, a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold.

Firebrick Pharma (ASX:FRE) Headlines

No Headlines